Literature DB >> 28239487

Angina Frequency After Acute Myocardial Infarction In Patients Without Obstructive Coronary Artery Disease.

Anna Grodzinsky1, Suzanne V Arnold1, Kensey Gosch1, John A Spertus1, JoAnne M Foody2, John Beltrame3, Thomas M Maddox4, Susmita Parashar5, Mikhail Kosiborod1.   

Abstract

BACKGROUND: Myocardial infarction (MI) patients without obstructive coronary artery disease (CAD) are at increased risk for recurrent ischemic events, but angina frequency post-MI has not been described. METHODS AND
RESULTS: Among MI patients who underwent angiography, we assessed angina at baseline, 1, 6, and 12 months using the Seattle Angina Questionnaire (SAQ). A hierarchical repeated measures modified Poisson model assessed the association between the absence of obstructive CAD (defined as epicardial stenoses >70% or left main >50%) and angina. Among 5539 MI patients from 31 US hospitals (mean age 60, 68% male), 6.9% had no angiographic obstructive CAD. More patients without obstructive CAD (vs. obstructive CAD) were female (57% vs 30%), non-white (51% vs 24%) and had NSTEMI (87% vs 51%). In unadjusted analyses, patients without obstructive CAD had less angina prior to MI but more angina and worse health status post-discharge. After adjustment for socio-demographic and clinical factors, the risk of post-MI angina was similar in patients without vs. with obstructive CAD (IRR=0.89, 95% CI 0.77-1.02). Among patients without obstructive CAD, depression and self-reported avoidance of care due to cost were independently associated with angina (IRR=1.28 per 5 points on PHQ, 95% CI 1.17-1.41; IRR=1.34, 95% 1.02-1.1.74).
CONCLUSIONS: Following MI, patients without obstructive CAD experience an angina burden at least as high as those with obstructive CAD, affecting 1 in 4 patients at 12 months. As these patients are not candidates for revascularization, other anti-anginal strategies are needed to improve their health status and quality of life.

Entities:  

Keywords:  Acute myocardial infarction; Angina; Coronary artery disease

Year:  2015        PMID: 28239487      PMCID: PMC5321550          DOI: 10.1093/ehjqcco/qcv014

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN: 2058-1742


  28 in total

1.  Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry.

Authors:  Thomas M Maddox; P Michael Ho; Matthew Roe; David Dai; Thomas T Tsai; John S Rumsfeld
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-10-05

2.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

3.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

Review 4.  Third universal definition of myocardial infarction: update, caveats, differential diagnoses.

Authors:  David M Tehrani; Arnold H Seto
Journal:  Cleve Clin J Med       Date:  2013-12       Impact factor: 2.321

5.  Psychosocial modulators of angina response to myocardial ischemia.

Authors:  Suzanne V Arnold; John A Spertus; Paul S Ciechanowski; Laurie A Soine; Kier Jordan-Keith; James H Caldwell; Mark D Sullivan
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

6.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

7.  The Prospective Registry Evaluating Myocardial Infarction: Events and Recovery (PREMIER)--evaluating the impact of myocardial infarction on patient outcomes.

Authors:  John A Spertus; Eric Peterson; John S Rumsfeld; Philip G Jones; Carole Decker; Harlan Krumholz
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

8.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.

Authors:  Lasse Jespersen; Anders Hvelplund; Steen Z Abildstrøm; Frants Pedersen; Søren Galatius; Jan K Madsen; Erik Jørgensen; Henning Kelbæk; Eva Prescott
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

9.  Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry.

Authors:  Suzanne V Arnold; Paul S Chan; Philip G Jones; Carole Decker; Donna M Buchanan; Harlan M Krumholz; P Michael Ho; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-07

10.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

View more
  14 in total

1.  Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA).

Authors:  Giancarlo Pirozzolo; Andreas Seitz; Anastasios Athanasiadis; Raffi Bekeredjian; Udo Sechtem; Peter Ong
Journal:  Clin Res Cardiol       Date:  2019-06-24       Impact factor: 5.460

Review 2.  Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease).

Authors:  Christine Pacheco Claudio; Odayme Quesada; Carl J Pepine; C Noel Bairey Merz
Journal:  Clin Cardiol       Date:  2018-03-02       Impact factor: 2.882

3.  [MINOCA-myocardial infarction with non-obstructive coronary arteries].

Authors:  C Hamm; C W Hamm
Journal:  Herz       Date:  2018-12       Impact factor: 1.443

Review 4.  Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.

Authors:  Puja K Mehta; Odayme Quesada; Ahmed Al-Badri; Jerome L Fleg; Annabelle Santos Volgman; Carl J Pepine; C Noel Bairey Merz; Leslee J Shaw
Journal:  Int J Cardiol       Date:  2021-12-11       Impact factor: 4.164

Review 5.  Mechanisms of Coronary Ischemia in Women.

Authors:  Jingwen Huang; Sonali Kumar; Olga Toleva; Puja K Mehta
Journal:  Curr Cardiol Rep       Date:  2022-07-29       Impact factor: 3.955

Review 6.  Disparities in Cardiac Care of Women: Current Data and Possible Solutions.

Authors:  Rosalyn O Adigun; Amber N Boler; Rekha Mankad
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-09-21

7.  Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.

Authors:  Rachel P Dreyer; Rosanna Tavella; Jeptha P Curtis; Yongfei Wang; Sivabaskari Pauspathy; John Messenger; John S Rumsfeld; Thomas M Maddox; Harlan M Krumholz; John A Spertus; John F Beltrame
Journal:  Eur Heart J       Date:  2020-02-14       Impact factor: 35.855

8.  Using patient-reported outcome measures for primary percutaneous coronary intervention.

Authors:  Esther Kwong; Jenny Neuburger; Steffen Erhard Petersen; Nick Black
Journal:  Open Heart       Date:  2019-02-16

9.  Is Vasospastic Coronary Disease More Common Than We Realize?

Authors:  Anum S Minhas; Erin D Michos; Allison G Hays
Journal:  JACC Case Rep       Date:  2022-03-02

10.  Role of cardiac CT in the diagnostic evaluation and risk stratification of patients with myocardial infarction and non-obstructive coronary arteries (MINOCA): rationale and design of the MINOCA-GR study.

Authors:  Georgios P Rampidis; Polydoros Ν Kampaktsis; Konstantinos Kouskouras; Athanasios Samaras; Georgios Benetos; Andreas Α Giannopoulos; Theodoros Karamitsos; Alexandros Kallifatidis; Antonios Samaras; Ioannis Vogiatzis; Stavros Hadjimiltiades; Antonios Ziakas; Ronny R Buechel; Catherine Gebhard; Nathaniel R Smilowitz; Konstantinos Toutouzas; Konstantinos Tsioufis; Panagiotis Prassopoulos; Haralambos Karvounis; Harmony Reynolds; George Giannakoulas
Journal:  BMJ Open       Date:  2022-02-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.